Skip to Main Content

Paper Details

Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
Acta Neuropathol
5
2022
ALK, NTRK2, infant-type hemispheric glioma, pleomorphic xanthoastrocytomas, receptor tyrosine kinase fusions
Author NameAffiliation
Calixto-Hope G LucasUniversity of California san francisco
Calixto-Hope G LucasUniversity of California san francisco
Zied AbdullaevCenter for Cancer Research, National Cancer Institute
Kanish MirchiaUniversity of California san francisco
Samuel H CheshierUniversity of Utah
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsUniversity of California san francisco
Joanna J PhillipsUniversity of California san francisco
David A SolomonUniversity of California san francisco
David A SolomonUniversity of California san francisco
Martha QuezadoCenter for Cancer Research, National Cancer Institute
Martha QuezadoCenter for Cancer Research, National Cancer Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Arie PerryUniversity of California san francisco
Arie PerryUniversity of California san francisco
Arie PerryUniversity of California san francisco
Arie PerryUniversity of California san francisco
  • 1 - 19

Datasets